Steven Saenz
About Steven Saenz
Steven Saenz is a Senior Principal Scientist at Bristol Myers Squibb in Cambridge, Massachusetts, with extensive experience in translational science and a strong background in immunology and microbiology.
Title and Current Position
Steven Saenz holds the title of Senior Principal Scientist at Bristol Myers Squibb, based in Cambridge, Massachusetts, United States. His role involves significant contributions to the scientific and biotech community within the area.
Previous Experience at Celgene
Prior to his current position, Steven Saenz worked at Celgene in Cambridge, MA. He held the roles of Senior Scientist from 2018 to 2021 and Scientist II, Translational Development from 2016 to 2021. During his tenure, he was heavily involved in translational development, focusing on moving scientific discoveries from the laboratory to clinical applications.
Academic and Post-Doctoral Background
Steven Saenz completed his Doctor of Philosophy (PhD) in Microbiology and Immunology at the University of Pennsylvania, where he studied from 2005 to 2013. His post-doctoral fellowship at the same university from 2011 to 2013 was rich in projects related to immunology and microbiology.
Experience at Biogen
Steven Saenz worked at Biogen as Scientist I from 2013 to 2016. This role further augmented his extensive background in translational science and bolstered his expertise in bridging the gap between academic research and industry applications.
Contributions to the Scientific Community
With over a decade of presence in Cambridge, MA, Steven Saenz has significantly contributed to various advancements in the biotech sector. His rich experience in both academic and industry settings underscores his commitment to the development of innovative therapies and translational science.